Twitxy Saved

David Steensma, MD

@DavidSteensma

Hematologist-oncologist. @AjaxThx CMO. Former Edward P. Evans Chair in MDS @DanaFarber, @HarvardMed & @MayoClinic faculty, @NovartisScience hematology head.
Cambridge, Massachusetts, USA Joined August 2014
453 Following 27K Followers 8K Posts

Latest posts 5

David Steensma, MD @DavidSteensma
Great to seen John Mascarenhas from @IcahnMountSinai presenting first clinical data from our @AjaxThx AJX-101 trial at #EHA26. A highly active agent for patients with myelofibrosis, based on @rosslevinemd & collaborators science. AJ1-11095 is now part of @EliLillyandCo pipeline
👉👉👉****Very important oral presentation #EHA26 #EHA2026 | John Mascarhenas | @EHA_Hematology AJX-101 ph1 results Type II JAK2i in patients with prior JAK2i | n=23 | #DiseaseModification with Both high SVR35 and TSS50 reductions in R/R setting| ********| @mpdrc #MPNSM
View quoted post on X
2 replies 7 reposts 24 likes 3.9K views View on X